Stay updated on PV-10 with Pembrolizumab in Melanoma Clinical Trial
Sign up to get notified when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.

Latest updates to the PV-10 with Pembrolizumab in Melanoma Clinical Trial page
- Check2 days agoChange DetectedUpdated to v3.0.2. Removes the Melanoma topic under MedlinePlus Genetics (a core content item) and removes the Back to Top link along with the older v3.0.1 reference.SummaryDifference0.4%
- Check9 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1.SummaryDifference0.2%
- Check16 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as the introduction of new medical terms related to skin and connective tissue diseases and specific treatments. Notably, the version has been updated from v2.16.12 to v3.0.0.SummaryDifference2%
- Check23 days agoNo Change Detected
- Check31 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check38 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check45 days agoChange DetectedThe page has been updated to version v2.16.10, and the previous service alert regarding planned maintenance has been removed.SummaryDifference1.0%
Stay in the know with updates to PV-10 with Pembrolizumab in Melanoma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PV-10 with Pembrolizumab in Melanoma Clinical Trial page.